The aberrant c-myc expression in CRC is responsible for the cancer metabolic reprogramming, in which c-Myc induces 215 metabolic reactions by changing the expression levels of 121 metabolic genes and 39 transporter genes [12]. This evidence concerns the gene MYC and colorectal carcinoma.